Prof. Manuel Carrondo, IBET’s CEO and ITQB Researcher, has been invited to join the Scientific Advisory Board (SAB) of the Spanish National Center for Cardiovascular Research Carlos III (CNIC)’s Translational Department (DI CT) (www.cnic.es).
“Pathological modeling, drug discovery and toxicity testing using pluripotent stem cells”
The CliniGene Network of Excellence (NoE) is organising a public meeting on April 7-9 th 2011, in Paris.
GeniBET will be present at Bio-Europe in Milan, Italy, on 14-16 March.
The Genomic Forestry Meeting: "Eucalyptus meet genomics” brought together experts in one of the first meetings dedicated to this emerging field.
Optimizing Downstream Processing of Enveloped Viruses, Tiago Vicente, Cristina Peixoto, José P. B. Mota, Manuel J.T. Carrondo, Paula M. Alves
IBET participates in the celebration of the 100 years of Bayer business in Portugal
IBET’s CEO, will co-chair a Seminar on "Reviewing the response to the 2009 influenza pandemic: what has changed as a result of the pandemic threat?”
Bayer Schering Pharma AG and IBET collaborate on a new research project
On October 8, 2010, iBET had a meeting with the Consuting Board, Partner's and iBET Researchers to evaluate the future of iBET.